Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals
about
Incidence and predictors of first line antiretroviral regimen modification in western KenyaInitiating antiretrovirals during tuberculosis treatment: a drug safety review.Timing of antiretroviral therapy and regimen for HIV-infected patients with tuberculosis: the effect of revised HIV guidelines in Malawi.Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection.Drug-drug interactions and tolerance in combining antituberculosis and antiretroviral therapy.Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the InternatiAdverse effects of highly active antiretroviral therapy in developing countries.Management of multidrug-resistant tuberculosis: Update 2007.Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy.Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.Prevalent neuropathy in a cohort of HIV-infected Kenyan sex workers using antiretroviral drugs.Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN.Peripheral neuropathy in HIV-positive patients at an antiretroviral clinic in Lilongwe, Malawi.Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study.
P2860
Q28541822-9768BECB-00B2-4D1B-8729-C308B2FDBE7CQ35043048-DB1A32E1-77A5-4FAC-A11C-E0A48AB4E25EQ35098738-8BACC9D9-5E86-4629-915C-87C6EC2B4799Q36225416-A515A7F3-31D4-4B34-A7F2-7C0DBD1B193EQ36235489-CB56765E-F286-47E4-8EDD-5D6C45A324A1Q36304546-7F53D1F6-430F-4099-B878-D0E947CD3F98Q36945761-B4307A5C-3F3F-4389-A90F-4A49F0B02F94Q37058166-2BC5B6AE-66F9-4C1E-BD5E-D148ABE3D5ADQ37453634-6169EA6C-94A6-4CC9-8B07-7B9456A4CED7Q37584886-98882031-CAFE-48E3-A6E4-AF47A7EDA002Q37608857-C81FE622-5746-4AC2-B122-EC19BFDE572BQ37973439-E3614CA0-8AA8-4E46-9B78-64DB38187196Q39306109-4B20DC5A-961E-454B-9C1D-5AF68930FBF7Q41219108-BFF4B317-9623-4EB6-854E-68FD535D3BF7
P2860
Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Increased incidence of periphe ...... id in HIV-infected individuals
@ast
Increased incidence of periphe ...... id in HIV-infected individuals
@en
Increased incidence of periphe ...... id in HIV-infected individuals
@nl
type
label
Increased incidence of periphe ...... id in HIV-infected individuals
@ast
Increased incidence of periphe ...... id in HIV-infected individuals
@en
Increased incidence of periphe ...... id in HIV-infected individuals
@nl
prefLabel
Increased incidence of periphe ...... id in HIV-infected individuals
@ast
Increased incidence of periphe ...... id in HIV-infected individuals
@en
Increased incidence of periphe ...... id in HIV-infected individuals
@nl
P2093
P1433
P1476
Increased incidence of periphe ...... id in HIV-infected individuals
@en
P2093
M A Johnson
M C Lipman
P356
10.1097/00002030-200003310-00017
P407
P577
2000-03-31T00:00:00Z